Xu, M., Pu, Y., Jiang, Y., Liu, Y., Feng, Y., Zhao, X., Li, M. (2025). Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinoma. Scientific Reports. https://doi.org/10.1038/s41598-025-06625-2